Mucosal multivalent NDV-based vaccine provides cross-reactive immune responses against SARS-CoV-2 variants in animal models
2025 · Frontiers in Immunology · 8 citations
https://doi.org/10.3389/fimmu.2025.1524477
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
10
Papers
36
Citations
4
h-index
1
i10-index
Adam Abdeljawad is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & vaccines and immunoinformatics approaches & Influenza Virus Research Studies. The author has an h-index of 4, co-authored 9 publications.
https://doi.org/10.3389/fimmu.2025.1524477
https://doi.org/10.1016/j.vaccine.2024.126586
Click to start Chat